Simplex Trading’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-18,166
| Closed | -$608K | – | 10224 |
|
|
2026
Q1 | $608K | Sell |
18,166
-30,942
| -63% | -$1.21M | ﹤0.01% | 3044 |
|
|
2025
Q4 | $2.27M | Buy |
49,108
+23,999
| +96% | +$1.32M | ﹤0.01% | 1878 |
|
|
2025
Q3 | $1.7M | Buy |
+25,109
| New | +$1.86M | ﹤0.01% | 2484 |
|
|
2025
Q1 | – | Sell |
-10,216
| Closed | -$497K | – | 9580 |
|
|
2024
Q4 | $459K | Buy |
+10,216
| New | +$529K | ﹤0.01% | 3636 |
|
|
2024
Q1 | – | Sell |
-4,192
| Closed | -$190K | – | 9794 |
|
|
2023
Q4 | $168K | Buy |
+4,192
| New | +$119K | ﹤0.01% | 4840 |
|
|
2022
Q2 | – | Sell |
-10
| Closed | -$28 | – | 10994 |
|
|
2022
Q1 | $0 | Buy |
+10
| New | +$52 | ﹤0.01% | 11312 |
|
|
2021
Q4 | – | Sell |
-2,516
| Closed | -$26.4K | – | 11348 |
|
|
2021
Q3 | $42K | Hold |
2,516
| – | – | ﹤0.01% | 7735 |
|
|
2021
Q2 | $43K | Buy |
2,516
+324
| +15% | +$5.47K | ﹤0.01% | 7835 |
|
|
2021
Q1 | $41K | Buy |
2,192
+1,074
| +96% | +$34.6K | ﹤0.01% | 6835 |
|
|
2020
Q4 | $32K | Buy |
+1,118
| New | +$32.3K | ﹤0.01% | 6616 |
|
Simplex Trading's SLNO Position: Q2 2026 in Review
Simplex Trading sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 18,166 shares — an estimated $608K sold.
Simplex Trading first reported a position in SLNO in Q4 2020 and held it in 10 quarters. The position peaked at $2.27M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Simplex Trading reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 18,166 Soleno Therapeutics shares in Q2 2026, an estimated $608K.
- Simplex Trading first reported a position in Soleno Therapeutics in Q4 2020 and held it in 10 quarters.
- Simplex Trading's Soleno Therapeutics position peaked at $2.27M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.